Latest Updates

“We Basically Don’t Know What’s in These Vaccines” FLCCC Educational Conference Live! Day 2

Updated 2:25 PM (EST) It's A Wrap; Featured Speakers Take Audience Q&A to End Conference   Updated 2:00 PM (EST)  Ozone Therapy and COVID Dr. Asher Milgrom, Chief Scientist, AMA Regenerative Medicine & Skincare, delivered the final presentation of the conference, Ozone Therapy and the Role of Apheresis and Other Therapies in Refractory Cases, via special video presentation.   Updated 1:30 PM (EST) Getting (HOT) in Here -- Dr. Harch spoke on the unique benefits [...]

October 16, 2022|Latest Updates|

Paxlovid: Informed Choice

Paxlovid: A Guide to Making an Informed Decision - This Q&A from the Canadian COVID Care Alliance answers a number of targeted questions to better understand the oral antiviral medication currently being offered for COVID treatment.

August 2, 2022|Latest Updates|

FLCCC Mourns Dr. Vladimir Zelenko, Early COVID treatment Advocate

FLCCC mourns the loss of Dr. Vladimir Zelenko, fierce advocate for early COVID treatment The entire team at FLCCC is saddened to hear of the loss of a great friend and fellow supporter of early treatment for COVID-19. We extend our deepest condolences and sympathies to the Zelenko family and pray they find the strength to see them through this difficult time. “Dr. Zelenko stepped up and fought for access to early treatment when few others did,” said Dr. Pierre Kory, President and Chief Medical Officer of FLCCC. “He had a huge impact, and his loss will be felt by many.”

June 30, 2022|Latest Updates|

FLCCC Response to ACTIV-6 Trial Results on COVID Treatments

ACTIV-6 severely limited the use of ivermectin, administering a dose below what is known to be effective on the variants at the time and received too late (6 days on average) after the onset of symptoms. Despite these obvious shortfalls, there was a statistically significant, albeit modest, impact on time to clinical recovery for patients using ivermectin to treat COVID-19. T

June 14, 2022|Latest Updates|
Go to Top